ArticleMolecules (Basel, Switzerland)2020

Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.

Christina Baun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.